S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
NASDAQ:JYNT

Joint (JYNT) Stock Price, News & Analysis

$13.06
+0.29 (+2.27%)
(As of 03/28/2024 ET)
Today's Range
$12.68
$13.29
50-Day Range
$9.04
$13.09
52-Week Range
$7.31
$16.92
Volume
63,876 shs
Average Volume
100,488 shs
Market Capitalization
$193.03 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$21.50

Joint MarketRank™ Stock Analysis

Analyst Rating
Hold
2.33 Rating Score
Upside/​Downside
64.6% Upside
$21.50 Price Target
Short Interest
Healthy
5.73% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
1.43mentions of Joint in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
284.62%
From $0.13 to $0.50 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.42 out of 5 stars

Medical Sector

368th out of 938 stocks

Patent Owners & Lessors Industry

3rd out of 6 stocks

JYNT stock logo

About Joint Stock (NASDAQ:JYNT)

The Joint Corp. operates and franchises chiropractic clinics in the United States. The company operates in two segments, Corporate Clinics and Franchise Operations. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.

JYNT Stock Price History

JYNT Stock News Headlines

On Holding Posts Adj. Loss In Q4 - Quick Facts
Trump’s “Tax Free” Retirement Strategy
Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.
Trump’s “Tax Free” Retirement Strategy
Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.
Joint Q4 2023 Earnings Preview
Best joint personal loans of February 2024
The Joint Corp (JYNT)
The Joint Corp. Reports 2023 Operating Metrics
How to Get a Joint Personal Loan
Best joint checking accounts of January 2024
Returns Are Gaining Momentum At Joint (NASDAQ:JYNT)
The Joint Corp JYNT
See More Headlines
Receive JYNT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Joint and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
9/13/2023
Today
3/28/2024
Next Earnings (Estimated)
5/02/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Patent owners & lessors
Sub-Industry
N/A
Current Symbol
NASDAQ:JYNT
Employees
444
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$21.50
High Stock Price Target
$30.00
Low Stock Price Target
$13.00
Potential Upside/Downside
+64.6%
Consensus Rating
Hold
Rating Score (0-4)
2.33
Research Coverage
3 Analysts

Profitability

Net Income
$-9,750,000.00
Pretax Margin
1.39%

Debt

Sales & Book Value

Annual Sales
$117.70 million
Cash Flow
$0.76 per share
Book Value
$1.68 per share

Miscellaneous

Free Float
14,185,000
Market Cap
$193.03 million
Optionable
Optionable
Beta
1.57
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Key Executives

  • Mr. Peter D. Holt (Age 65)
    CEO, President & Director
    Comp: $469.55k
  • Jake SingletonJake Singleton (Age 42)
    Chief Financial Officer
    Comp: $280.92k
  • Mr. Jorge Armenteros
    Senior Vice President of Operations
  • Mr. Charles Nelles
    Chief Technology Officer
  • Dr. Steven Knauf
    Vice President of Chiropractic & Compliance
  • Ms. Lori I. Abou Habib (Age 44)
    Chief Marketing Officer
  • Ms. Krischelle Tennessen
    Chief Human Resources Officer
  • Mr. Eric Simon
    Senior VP of Franchise Sales & Development
  • Mr. Craig P. Colmar J.D. (Age 71)
    Secretary
    Comp: $37k

JYNT Stock Analysis - Frequently Asked Questions

Should I buy or sell Joint stock right now?

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Joint in the last twelve months. There are currently 2 hold ratings and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" JYNT shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in JYNT, but not buy additional shares or sell existing shares.
View JYNT analyst ratings
or view top-rated stocks.

What is Joint's stock price target for 2024?

3 brokers have issued 12-month price targets for Joint's stock. Their JYNT share price targets range from $13.00 to $30.00. On average, they expect the company's share price to reach $21.50 in the next year. This suggests a possible upside of 64.6% from the stock's current price.
View analysts price targets for JYNT
or view top-rated stocks among Wall Street analysts.

How have JYNT shares performed in 2024?

Joint's stock was trading at $9.61 at the beginning of 2024. Since then, JYNT stock has increased by 35.9% and is now trading at $13.06.
View the best growth stocks for 2024 here
.

Are investors shorting Joint?

Joint saw a decrease in short interest in the month of March. As of March 15th, there was short interest totaling 846,900 shares, a decrease of 10.8% from the February 29th total of 949,000 shares. Based on an average trading volume of 99,500 shares, the short-interest ratio is presently 8.5 days.
View Joint's Short Interest
.

When is Joint's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 2nd 2024.
View our JYNT earnings forecast
.

How were Joint's earnings last quarter?

The Joint Corp. (NASDAQ:JYNT) issued its earnings results on Wednesday, September, 13th. The company reported ($0.01) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.01 by $0.02. The company earned $29.31 million during the quarter, compared to analysts' expectations of $29.85 million. Joint had a negative net margin of 8.19% and a positive trailing twelve-month return on equity of 7.80%.

What is Peter D. Holt's approval rating as Joint's CEO?

87 employees have rated Joint Chief Executive Officer Peter D. Holt on Glassdoor.com. Peter D. Holt has an approval rating of 59% among the company's employees. This puts Peter D. Holt in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Joint own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Joint investors own include Advanced Micro Devices (AMD), RTX (RTX), Salesforce (CRM), Mastercard (MA), Starbucks (SBUX), Twitter (TWTR), Viking Therapeutics (VKTX), AbbVie (ABBV) and Adobe (ADBE).

When did Joint IPO?

Joint (JYNT) raised $20 million in an IPO on Tuesday, November 11th 2014. The company issued 3,000,000 shares at $6.50 per share. Roth Capital Partners and Feltl and Company served as the underwriters for the IPO and Sanders Morris Harris was co-manager.

Who are Joint's major shareholders?

Joint's stock is owned by many different retail and institutional investors. Top institutional investors include Vanguard Group Inc. (6.99%), Vanguard Group Inc. (6.99%), Skylands Capital LLC (4.09%), Dimensional Fund Advisors LP (1.21%), Northern Trust Corp (0.92%) and Russell Investments Group Ltd. (0.56%). Insiders that own company stock include Bandera Partners Llc, Glenn J Krevlin, Jake Singleton, James H Amos Jr, Matthew E Rubel, Matthew E Rubel, Peter D Holt and Ronald V Davella.
View institutional ownership trends
.

How do I buy shares of Joint?

Shares of JYNT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:JYNT) was last updated on 3/29/2024 by MarketBeat.com Staff

From Our Partners